Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,789Revenue $M274Net Margin (%)30.5Z-Score28.6
Enterprise Value $M1,638EPS $1.6Operating Margin %47.7F-Score7
P/E(ttm))18.9Cash Flow Per Share $0.4Pre-tax Margin (%)48.2Higher ROA y-yY
Price/Book5.410-y EBITDA Growth Rate %0Quick Ratio6.0Cash flow > EarningsN
Price/Sales5.85-y EBITDA Growth Rate %55.3Current Ratio7.1Lower Leverage y-yY
Price/Cash Flow14.2y-y EBITDA Growth Rate %966ROA % (ttm)33.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)38.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M35.8ROI % (ttm)8.9Gross Margin Increase y-yY

Gurus Latest Trades with LCI

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LCIJoel Greenblatt 2014-09-30 Add0.12%$34.05 - $51.19
($39.77)
$ 48.9323%Add 749.49%303,345
LCIJoel Greenblatt 2014-06-30 Buy 0.02%$29.62 - $49.76
($39.16)
$ 48.9325%New holding, 35709 sh.35,709
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LCI is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
LCI Joel Greenblatt 2014-09-30303,3450.850.14+749.49%
Premium Most recent portfolio changes are included for Premium Members only!


LCI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BEDROSIAN ARTHUR PCEO 2015-01-15Sell5,000$43.512.48view
FARBER DAVID10% Owner 2015-01-15Sell5,000$43.5212.43view
BEDROSIAN ARTHUR PCEO 2014-12-15Sell5,000$43.8111.69view
FARBER DAVID10% Owner 2014-12-15Sell5,000$43.8111.69view
Maher James M.Director 2014-12-10Buy250$42.9613.9view
GALVAN MARTIN PVP of Finance & CFO 2014-12-10Buy1,000$42.415.4view
Sabo ErnestVP, Regulatory and CCO 2014-12-08Sell6,000$48.031.87view
Maher James M.Director 2014-12-02Buy500$46.535.16view
FARBER DAVID10% Owner 2014-11-26Sell7,500$50-2.14view
Sabo ErnestVP, Regulatory and CCO 2014-11-26Sell3,000$50.04-2.22view

Press Releases about LCI :

Quarterly/Annual Reports about LCI:

News about LCI:

Articles On GuruFocus.com
Lannett Company Looks Cheap At First Glance; But It Is Actually Much Cheaper Than It Looks Dec 29 2014 
comment on LCI Nov 19 2012 
comment on LCI Nov 13 2012 
comment on LCI Jan 26 2012 
comment on LCI Jan 26 2012 
comment on LCI Jan 23 2012 
comment on LCI Jan 23 2012 
Lannett Company Inc Reports Operating Results (10-Q) Nov 12 2010 
Lannett Company Inc Reports Operating Results (10-K) Sep 24 2010 
View on LCI May 17 2010 


More From Other Websites
Stocks Finished Modestly Higher In Light Trade Jan 26 2015
LANNETT CO INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jan 26 2015
Stocks Narrowly Mixed Going Into Last Hour Jan 26 2015
Lannett Early Q2 Earnings Beat Estimates; Stock Jumps Jan 26 2015
7:56 am Lannett sees Q2 EPS guidance of $1.18-1.21 vs $0.93 Capital IQ Consensus Est, sees revenue... Jan 26 2015
Lannett Announces Preliminary Fiscal 2015 Second Quarter Net Sales of Approximately $115 Million,... Jan 26 2015
LANNETT CO INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,... Jan 23 2015
OncoGenex's AFFINITY on Track, Passes Futility Analysis - Analyst Blog Jan 19 2015
UCB-Neuropore Collaborate for Parkinson's Disease Therapy - Analyst Blog Jan 19 2015
LANNETT CO INC Files SEC form 8-K, Regulation FD Disclosure Jan 14 2015
Lannett to Present at the 33rd Annual J.P. Morgan Healthcare Conference on January 14 Jan 05 2015
Lannett Receives FDA Approval for Dorzolamide HCL with Timolol Dec 18 2014
Stocks Off Lows In Afternoon: AutoZone Hits New High Dec 09 2014
Cempra (CEMP) in Focus: Stock Rises 11.4% in Session Dec 09 2014
Tetraphase Pharmaceuticals (TTPH) Jumps: Stock Up 8.8% Dec 09 2014
LANNETT CO INC Files SEC form 8-K, Other Events Dec 08 2014
LANNETT CO INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Dec 05 2014
Lannett Names Michael Bogda as President Dec 05 2014
Ryanair Holdings (RYAAY) Jumps: Stock Adds 7.2% in Session Dec 05 2014
Lannett to Present at the Oppenheimer 25th Annual Healthcare Conference on December 10 Dec 02 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK